全国金奖背后——打破国外高端显微仪器的垄断 杨懿 杭州正汇聚人工智能的浪潮与顶尖的科研人才，向着大脑的奥秘深处进发—— 荷湖科技董事长杨懿带领团队研发的智能显微仪器，打破了国外在相关领域的长期垄断；在西湖灵 犀科技，曹路团队开发的植入式脑机接口芯片，成功将失语者的脑电波"翻译"成中文语句，让沉默的思 维重新"发声"。 曹路（左） 这两项融合了人工智能与脑科学的前沿成果，不仅代表了我国在尖端技术领域的自主创新能力，更 为脑疾病治疗、新药研发等带来了革命性的突破，展现了杭州在培育人工智能与生物医药交叉创新方面 的独特优势。 "我们发现，人工智能技术在治疗脑部疾病方面有着广阔的应用前景。"曹路在新加坡博士毕业后， 追随导师进入西湖大学，成为该校的博士后，在人工智能领域开展研究，"人工智能加上脑机接口或将 改变人类的交流方式，把相关技术应用到医学领域，能创造巨大的社会价值。" 浙江荷湖科技有限公司的实验室里，研究人员正研究小黑鼠的脑部神经活动。 研究人员为两只小黑鼠戴上公司研发的头戴式小型化智能显微镜，厘米见方的设备不足3克重，轻 巧得不妨碍小黑鼠在玻璃箱中嬉闹、追逐，行动轨迹被实时捕捉并呈现在电脑屏幕上。同时，它们 ...

Core Insights - The 17th China Bio-Industry Conference opened in Wuhan, marking it as the largest and most influential professional event in China's bio-industry sector [1] - The conference showcased significant innovations, including the world's first plant-derived recombinant human serum albumin injection, Aofumin®, developed by Wuhan Heyuan Biotechnology Co., Ltd. [2] - The conference highlighted various groundbreaking products, including a visual intervention robot system and an implantable brain-computer interface chip, attracting considerable attention from attendees [5] Industry Developments - The conference featured the world's first clinical research candidate for oncolytic virus therapy, OH2 injection, developed by Wuhan Binhui Biotechnology Co., Ltd. [5] - The "China Bio-Economy Development Report 2025" was released, indicating that China's bio-economy industry remains the largest globally and is experiencing continuous growth [10] - Wuhan has established itself as a permanent host for the China Bio-Industry Conference since 2018, developing a comprehensive bio-pharmaceutical industry cluster with a scale exceeding 550 billion yuan [10]